umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
Umeå universitet, Medicinska fakulteten, Institutionen för kirurgisk och perioperativ vetenskap, Urologi och andrologi. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Vise andre og tillknytning
2017 (engelsk)Inngår i: International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, E-ISSN 1879-355X, Vol. 97, nr 5, s. 1026-1031Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Purpose: To investigate the risk of thromboembolic disease (TED) after radiation therapy (RT) with curative intent for prostate cancer (PCa). Patients and Methods: We identified all men who received RT as curative treatment (n=9410) and grouped according to external beam RT (EBRT) or brachytherapy (BT). By comparing with an age-and county-matched comparison cohort of PCa-free men (n = 46,826), we investigated risk of TED after RT using Cox proportional hazard regression models. The model was adjusted for tumor characteristics, demographics, comorbidities, PCa treatments, and known risk factors of TED, such as recent surgery and disease progression. Results: Between 2006 and 2013, 6232 men with PCa received EBRT, and 3178 underwent BT. A statistically significant association was found between EBRT and BT and risk of pulmonary embolism in the crude analysis. However, upon adjusting for known TED risk factors these associations disappeared. No significant associations were found between BT or EBRT and deep venous thrombosis. Conclusion: Curative RT for prostate cancer using contemporary methodologies was not associated with an increased risk of TED.

sted, utgiver, år, opplag, sider
Elsevier, 2017. Vol. 97, nr 5, s. 1026-1031
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-136082DOI: 10.1016/j.ijrobp.2017.01.218ISI: 000401128500026PubMedID: 28332985OAI: oai:DiVA.org:umu-136082DiVA, id: diva2:1109492
Tilgjengelig fra: 2017-06-14 Laget: 2017-06-14 Sist oppdatert: 2018-06-09bibliografisk kontrollert

Open Access i DiVA

fulltext(380 kB)151 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 380 kBChecksum SHA-512
eeda4962cc1ffe7893766f802b182833fdc1de76bd73e2a2a414035c9bc94c32bec3af1432a71639ef3bb4fc7bde54b75a86f1bb14537c52db105d544e5453f6
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Stattin, PärWidmark, Anders

Søk i DiVA

Av forfatter/redaktør
Stattin, PärWidmark, Anders
Av organisasjonen
I samme tidsskrift
International Journal of Radiation Oncology, Biology, Physics

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 151 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 445 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf